These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 6286147)
1. Molecular interactions in human T-cell-mediated cytotoxicity to Epstein-Barr virus. I. Blocking of effector cell function by monoclonal antibody OKT3. Tsoukas CD; Fox RI; Carson DA; Fong S; Vaughan JH Cell Immunol; 1982 May; 69(1):113-21. PubMed ID: 6286147 [No Abstract] [Full Text] [Related]
2. Long-term T-cell-mediated immunity to Epstein-Barr virus. Rickinson AB; Moss DJ; Wallace LE; Rowe M; Misko IS; Epstein MA; Pope JH Cancer Res; 1981 Nov; 41(11 Pt 1):4216-21. PubMed ID: 6272965 [No Abstract] [Full Text] [Related]
3. Lysis of autologous Epstein-Barr virus-infected B cells by cytotoxic T lymphocytes of rheumatoid arthritis patients. Tsoukas CD; Carson DA; Fong S; Slovin SF; Fox RI; Vaughan JH Clin Immunol Immunopathol; 1982 Jul; 24(1):8-14. PubMed ID: 6179673 [No Abstract] [Full Text] [Related]
4. T-lymphocyte subset interactions in the cell-mediated immune response to Epstein-Barr virus. Schooley RT; Arbit DI; Henle W; Hirsch MS Cell Immunol; 1984 Jul; 86(2):402-12. PubMed ID: 6329522 [TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies to Epstein-Barr virus-induced, transformation-associated cell surface antigens: binding patterns and effect upon virus-specific T-cell cytotoxicity. Rowe M; Hildreth JE; Rickinson AB; Epstein MA Int J Cancer; 1982 Apr; 29(4):373-81. PubMed ID: 6282762 [TBL] [Abstract][Full Text] [Related]
6. Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. II. Blocking studies with monoclonal antibodies to HLA determinants. Wallace LE; Moss DJ; Rickinson AB; McMichael AJ; Epstein MA Eur J Immunol; 1981 Sep; 11(9):694-9. PubMed ID: 6271557 [TBL] [Abstract][Full Text] [Related]
7. Molecular interactions in human T cell-mediated cytotoxicity to EBV II. Monoclonal antibody OKT3 inhibits a post-killer-target recognition/adhesion step. Tsoukas CD; Carson DA; Fong S; Vaughan JH J Immunol; 1982 Oct; 129(4):1421-5. PubMed ID: 6286765 [No Abstract] [Full Text] [Related]
8. Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. III. Establishment of HLA-restricted cytotoxic T cell lines using interleukin 2. Wallace LE; Rowe M; Gaston JS; Rickinson AB; Epstein MA Eur J Immunol; 1982 Dec; 12(12):1012-8. PubMed ID: 6297919 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of human T lymphocyte function with monoclonal antibodies. Dongworth DW; McMichael AJ Br Med Bull; 1984 Jul; 40(3):254-61. PubMed ID: 6205713 [No Abstract] [Full Text] [Related]
10. Interleukin 15-mediated induction of cytotoxic effector cells capable of eliminating Epstein-Barr virus-transformed/immortalized lymphocytes in culture. Sharif-Askari E; Fawaz LM; Tran P; Ahmad A; Menezes J J Natl Cancer Inst; 2001 Nov; 93(22):1724-32. PubMed ID: 11717333 [TBL] [Abstract][Full Text] [Related]
11. Regulation of antibody production by an antigen-specific EBV-transformed B-lymphoblastoid cell line: effect of high-dose antigen and antigen-pulsed T cells. McCaughan GW; Brown MH; Callard RE Immunology; 1986 Aug; 58(4):597-602. PubMed ID: 3015782 [TBL] [Abstract][Full Text] [Related]
12. Multiple HLA class I-dependent cytotoxicities constitute the "non-HLA-restricted" response in infectious mononucleosis. Strang G; Rickinson AB Eur J Immunol; 1987 Jul; 17(7):1007-13. PubMed ID: 2440688 [TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus-specific cytotoxic T-cell clones restricted through a single HLA antigen. Wallace LE; Rickinson AB; Rowe M; Epstein MA Nature; 1982 Jun; 297(5865):413-5. PubMed ID: 6176881 [No Abstract] [Full Text] [Related]
14. Monoclonal antibodies against leucoagglutinin-reactive human T lymphocyte surface components. Two antibodies which inhibit cell-mediated cytotoxicity at a post-binding stage. Vargas-Cortes M; Hammarström ML; Hammarström S; Hellström U; Perlmann P Eur J Immunol; 1986 Jul; 16(7):795-801. PubMed ID: 3522246 [TBL] [Abstract][Full Text] [Related]
15. Membrane antigen on Epstein--Barr virus-infected human B cells recognized by a monoclonal antibody. Slovin SF; Frisman DM; Tsoukas CD; Royston I; Baird SM; Wormsley SB; Carson DA; Vaughan JH Proc Natl Acad Sci U S A; 1982 Apr; 79(8):2649-53. PubMed ID: 6283539 [TBL] [Abstract][Full Text] [Related]
16. Specific lysis of varicella zoster virus-infected B lymphoblasts by human T cells. Hayward AR; Pontesilli O; Herberger M; Laszlo M; Levin M J Virol; 1986 Apr; 58(1):179-84. PubMed ID: 3005647 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of specific cell-mediated cytotoxicity by monoclonal antibodies to human T cell antigens. Platsoucas CD; Good RA Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4500-4. PubMed ID: 6974866 [TBL] [Abstract][Full Text] [Related]
18. Lectin-dependent cellular cytotoxicity by human lymphocytes is blocked by monoclonal antibodies to the sheep red cell receptor. Görög G; Laskay T; Petrányi GG Immunol Lett; 1985; 11(2):107-9. PubMed ID: 3936780 [TBL] [Abstract][Full Text] [Related]
19. Target level blocking of T-cell cytotoxicity for human malignant melanoma by monoclonal antibodies. Knuth A; Dippold W; Meyer zum Bueschenfelde KH Cell Immunol; 1984 Feb; 83(2):398-403. PubMed ID: 6198103 [TBL] [Abstract][Full Text] [Related]
20. Mechanisms of enhancement of Epstein-Barr virus-induced transformation of peripheral blood lymphocytes by a tumor promoter, TPA, with special reference to lowering of cytotoxicity of T cells. Harada S; Katsuki T; Yamamoto H; Hinuma Y Int J Cancer; 1981 May; 27(5):617-23. PubMed ID: 6270019 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]